CorMedix Inc. Cash Flow Statement
CRMD|13 years of annual SEC 10-K data (FY2013-FY2025)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 13 fiscal years. All figures from audited SEC 10-K filings.
CorMedix Inc. generated $175M in operating cash flow and $173M in free cash flow in FY2025. Free cash flow margin was 55.4% of revenue.
Based on SEC 10-K filings.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | $163.1M | -$17.9M | -$46.3M | -$28.2M | -$22.0M | -$16.4M | -$26.8M | -$33.0M | -$24.6M | -$20.5M | -$18.2M | -$20.5M | -$3.4M |
| Depreciation & Amortization | - | - | - | $61.9K | $128.0K | $73.3K | $74.2K | $36.9K | $25.6K | $15.1K | - | - | $7.0K |
| Operating Cash Flow | $175.0M | -$50.6M | -$38.4M | -$21.2M | -$22.0M | -$15.1M | -$23.7M | -$28.6M | -$22.3M | -$6.3M | -$12.5M | -$6.3M | -$2.3M |
| Capital Expenditures | $2.3M | $116.0K | $327.3K | $1.4M | $112.6K | $36.6K | $48.9K | $152.0K | $58.7K | $25.4K | $15.4K | $25.4K | $0 |
| Free Cash Flow | $172.8M | -$50.7M | -$38.7M | -$22.6M | -$22.1M | -$15.1M | -$23.7M | -$28.7M | -$22.3M | -$6.3M | -$12.5M | -$6.3M | -$2.3M |
| FCF Margin | 55.4% | -116.7% | - | -11826.2% | -9229.7% | -5326.6% | -5525.7% | -8726.6% | -9961.5% | -3352.9% | -5968.8% | -3352.9% | - |